NASDAQ: RNAZ Transcode Therapeutics, Inc. 8-K

Transcode Therapeutics schedules 2026 annual meeting for July 2, sets proposal deadline

Filed June 1, 2026 · Period ending May 29, 2026 · ~1 min read

2 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade RNAZ commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 1, 2026 3:11 PM